An Ultralong Bovine CDRH3 that Targets a Conserved, Cryptic Epitope on SARS-CoV and SARS-CoV-2 (2022)
Attributed to:
Development of Broadly Neutralising Antibodies Against SARS-CoV-2
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.04.06.487306
Publication URI: http://dx.doi.org/10.1101/2022.04.06.487306
Type: Preprint